Validating candidate endpoints for intermediate age-related macular degeneration trials in a multi-centre setting-lessons from the MACUSTAR study.
Eye (London, England)
View this publicationEye (London, England)
View this publicationLife science alliance
View this publicationNature communications
View this publicationPLoS neglected tropical diseases
View this publicationJournal for immunotherapy of cancer
View this publicationCell reports
View this publicationRheumatology (Oxford, England)
View this publicationNature nanotechnology
View this publicationMolecular nutrition & food research
View this publicationTranslational vision science & technology
View this publication